CINQAIR FDA approval date

The FDA approved CINQAIR on 23 Mar 2016.

FDA approval date
23 Mar 2016

Drug identity has not yet been verified against registry records

Also recorded as RESLIZUMAB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-03-23DayCINQAIRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761033", "applicant_as_listed_by_fda": "TEVA RESPIRATORY LLC", "brand_names": ["CINQAIR"], "active_ingredients": ["RESLIZUMAB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160323", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026